NASDAQ:LJPC - La Jolla Pharmaceutical Company
$8.56
 $-0.16
-1.78%
12:00PM EDT
2019-07-22
La Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients suffering from life-threatening diseases. LJPC-501 is its formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension (CRH). It has initiated a Phase III trial of LJPC-501 for the treatment of CRH, called the Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS) Phase III trial. LJPC-401 is its formulation of synthetic human hepcidin for the potential treatment of conditions characterized by iron overload, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease and myelodysplastic syndrome. LJPC-30S is its next-generation gentamicin derivative program that is focused on therapeutics for the potential treatment of serious bacterial infections, as well as rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  LJPC     avg for
industry  
  avg for
sector  
42 stocks weight:  1. 55   217. 37   399. 45  
42 stocks rank:  4. 46 K 1. 27 K 716. 99  
# analyst opinions:  5. 00   13. 21   13. 71  
mean recommendation:  2. 20   2. 10   2. 04  

quick ratio:  8. 24   5. 49   1. 88  
current ratio:  8. 65   5. 87   2. 36  

target price low:  6. 00   83. 44   114. 90  
target price avg:  19. 60   106. 20   137. 90  
target price high:  8. 59   132. 30   158. 97  
1-yr high:  34. 02   111. 86   142. 57  
last close:  8. 72   86. 79   125. 44  
50-day avg:  8. 09   86. 68   122. 63  
200-day avg:  9. 66   89. 22   121. 38  
1-yr low:  5. 24   69. 78   100. 51  
volume:  279. 71 K 2. 62 M 3. 43 M
50-day avg volume:  1. 51 M 3. 20 M 4. 16 M
200-day avg volume:  892. 70 K 2. 99 M 4. 75 M

1-day return:  -0. 68 % -1. 30 % -0. 99 %
this week return:  -8. 98 % 0. 45 % -0. 20 %
12-wk return:  14. 29 % 0. 94 % 4. 84 %
52-wk return:  -73. 30 % -1. 30 % 10. 55 %

enterprise value (EV):  255. 69 M 45. 10 B 122. 38 B
market cap:  236. 30 M 38. 96 B 108. 40 B
EBITDA:  -163. 68 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -1. 56   5. 38   11. 93  
enterprise/revenue (EV/R):  18. 74   57. 92   10. 21  
total revenue:  13. 64 M 9. 91 B 39. 98 B
total debt:  155. 50 M 10. 90 B 17. 48 B
debt/equity:  1. 38 K 57. 18   120. 05  
net income (common):  -180. 63 M 2. 07 B 4. 05 B

shares outstanding:  27. 08 M 538. 09 M 1. 24 B
shares:  14. 89 M 548. 00 M 1. 22 B
shares short:  6. 23 M 10. 98 M 11. 87 M
shares short prior month:  5. 07 M 9. 32 M 12. 05 M
short ratio:  2. 37   5. 60   3. 34  
short % of float:  37. 59 % 6. 48 % 2. 64 %
total cash/share:  5. 17   10. 98   9. 19  
total cash:  140. 02 M 5. 93 B 6. 10 B
free cash flow:  -79. 27 M 2. 92 B 4. 55 B
operating cash flow:  -139. 20 M 3. 80 B 5. 78 B

book value:  0. 27   13. 35   27. 45  
price/book:  31. 94   4. 60   8. 78  
gross profits:  -106. 49 M 7. 44 B 36. 13 B
operating margins:  -1233. 15 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -6. 82   2. 10   4. 23  
forward EPS:  -2. 52   3. 45   7. 10  
P/E:  -1. 28   1. 90   32. 10  
forward P/E:  -3. 46   6. 46   15. 47  
PE/G:  -0. 00   0. 70   -0. 54  
growth:  443. 30 % 265. 63 % 79. 11 %
earnings high:  -1. 09   0. 89   1. 68  
earnings avg:  -1. 13   0. 70   1. 57  
earnings low:  -1. 17   0. 46   1. 46  
revenue high:  6. 00 M 2. 57 B 11. 07 B
revenue avg:  5. 66 M 2. 51 B 10. 91 B
revenue low:  5. 49 M 2. 45 B 10. 73 B
return on assets:  -56. 12 % -2. 34 % 5. 28 %
return on equity:  -214. 12 % -90. 08 % 133. 53 %
revenue growth:  443. 30 % 265. 25 % 73. 68 %
revenue/share:  0. 52   12. 72   60. 04  

beta (1yr vs S&P500):  2. 34   1. 27   0. 91  
sharpe (1yr):  -0. 43   0. 16   0. 77  

held % insiders:  6. 08 % 6. 06 % 3. 29 %
held % institutions:  104. 64 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : LJPC
.    109.835 =       109.835 :: --> INITIAL WEIGHT <--
.    - 6.817 =       103.018 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.986 =       204.594 :: P/E factor
.    x 2.209 =        451.94 :: PE/G factor
.     x 1.27 =       574.033 :: beta factor
.    x 0.792 =       454.459 :: sharpe factor
.    x 2.526 =      1147.763 :: current ratio factor
.    x 1.067 =      1224.475 :: quick ratio factor
.    x 1.192 =      1460.127 :: short ratio factor
.    x 3.177 =      4639.462 :: revenue growth factor
.    x 1.324 =       6140.69 :: EV/R factor
.    x 1.223 =       7507.42 :: price-to-book factor
.    x 0.669 =      5018.711 :: debt-to-revenue factor
.    x 2.692 =     13509.477 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     28650.805 :: sector+industry 1-year gains factor
.    x 1.009 =     28920.927 :: industry 12-weeks return factor
.    x 1.308 =      37825.35 :: industry 2-weeks return factor
.    x 1.415 =     53518.435 :: 5-day avg > 50-day avg
.     / 2.19 =     24438.088 :: overall "drift" factor
.      x 0.0 =        10.264 :: largest single-day jump factor
.    x 0.118 =         1.213 :: low price factor
.    x 0.064 =         0.078 :: notable returns + performance factor
.    x 0.002 =           0.0 :: performance vs s&p500 factor
.                               --> PROJECTIONS <--
.    x 0.745 =           0.0 :: forward EPS factor
.    x 0.907 =           0.0 :: forward P/E factor
.    x 1.185 =           0.0 :: industry recommendation factor
.    x 1.954 =           0.0 :: company recommendation factor
.    x 1.003 =           0.0 :: factor historical industry gain for week 29
.   x 10.642 =         0.003 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.    + 1.545 =         1.548 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      1.548 :: FINAL WEIGHT for NASDAQ:LJPC


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org